Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study

Published:2024-07 Issue:7 Volume:11 Page:e487-e498
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Salamero Olga,Molero Antonieta,Pérez-Simón José Antonio,Arnan Montserrat,Coll Rosa,Garcia-Avila Sara,Acuña-Cruz Evelyn,Cano Isabel,Somervaille Tim C P,Gutierrez Sonia,Arévalo María Isabel,Xaus Jordi,Buesa Carlos,Limón Ana,Faller Douglas V,Bosch Francesc,Montesinos Pau

Publisher

Elsevier BV

Reference22 articles.

1. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts;Dombret;Blood,2015

2. Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy;Zeidan;Blood,2022

3. Azacitidine and venetoclax in previously untreated acute myeloid leukemia;DiNardo;N Engl J Med,2020

4. Long-term follow-up of the phase 3 viale-a clinical trial of venetoclax plus azacitidine for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy;Pratz;Blood,2022

5. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML;DiNardo;Blood,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP